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Orexin (OX) neuropeptides stimulate feeding and
arousal. Deficiency of orexin is implicated in narco-
lepsy, a disease associated with obesity, paradoxi-
cally in the face of reduced food intake. Here, we
show that obesity in orexin-null mice is associated
with impaired brown adipose tissue (BAT) thermo-
genesis. Failure of thermogenesis in OX-null mice is
due to inability of brown preadipocytes to differen-
tiate. The differentiation defect in OX-null neonates
is circumvented by OX injections to OX-null dams.
In vitro, OX, triggers the full differentiation program
in mesenchymal progenitor stem cells, embryonic fi-
broblasts and brown preadipocytes via p38 mitogen
activated protein (MAP) kinase and bone morpho-
genetic protein receptor-1a (BMPR1A)-dependent
Smad1/5 signaling. Our study suggests that obesity
associated with OX depletion is linked to brown-fat
hypoactivity, which leads to dampening of energy
expenditure. Thus, orexin plays an integral role in
adaptive thermogenesis and body weight regulation
via effects on BAT differentiation and function.
INTRODUCTION
Orexin A and B are multifunctional neuropeptides that bind to
two receptors, orexin receptors -1 and -2 (OXR1 and OXR2), to
regulate sleep-wake cycles, physical activity and appetite
(Chemelli et al., 1999; Lin et al., 1999). The discovery of orexin
(OX) deficiency in human narcolepsy (Nishino et al., 2000; Than-
nickal et al., 2000) prompted researchers to investigate OX’s role
in metabolism in general, and in the pathophysiology of the
disease. These studies point toward a catabolic role of OX in
energy expenditure. Thus, central injection of OX elevates
sympathetic outflow, physical activity, metabolic rate, and ther-
mogenesis, (Hara et al., 2001; Lubkin and Stricker-Krongrad,
1998; Monda et al., 2003, 2004, 2007; Wang et al., 2001; Zhang
et al., 2007, 2010). Other studies, however, suggest that OX
reduces thermogenesis (Verty et al., 2010) and energy expendi-
ture (Haynes et al., 2002). These contrasting observations likely
originate from site-specific application of OX, given that the
receptors have differential expression and binding affinities for
orexins (Teske et al., 2010). Nevertheless, these reports demon-478 Cell Metabolism 14, 478–490, October 5, 2011 ª2011 Elsevier Instrate that OX signaling impacts energy homeostasis and body
weight control in both humans and mice.
Brown adipose tissue (BAT) thermogenesis and EE is con-
trolled by UCP1 (Cannon and Nedergaard, 2004). Since central
OX infusion elevates body temperature, Yoshimichi and
colleagues (2001) and Russell et al. (2002) investigated whether
OX’s thermogenic effect was mediated via UCP1. Surprisingly,
both the studies found that BAT UCP1 messenger RNA
(mRNA) expression is not induced by central OX administration.
These findings prompted Tsuneki and colleagues (2010) to
discount UCP1’s involvement in mediating OX’s catabolic and
thermogenic functions (Tsuneki et al., 2010). Mammals can
also elevate their core body temperature by a different mecha-
nism, called the ‘‘stress fever’’ (Dimicco and Zaretsky, 2007).
Recently, Zhang and colleagues compared the response of
OX-null mice and OX neuron-ablated mice to handling stress
(Zhang et al., 2010). The authors found that OX-null mice
behaved similar to wild-type controls. In contrast, the mice
without OX neurons lacked the stress-induced thermogenic
response. This indicated that OX-producing neurons but not
the peptide itself might be responsible for stress-induced
thermogenesis, a process that is largely attributable to BAT.
The study suggests the importance of coexistent neuromodula-
tors in the orexin neurons that may play a critical role in stress-
induced hyperthermia (Zhang et al., 2010). The molecular basis
of OX’s catabolic role in EE and thermogenesis however,
remains unclear.
The association between obesity and narcolepsy was first
noted about eight decades ago (Cave, 1931; Daniels, 1934).
Since then, several studies have reinforced the association
between the two (Bell, 1976; Cave, 1931; Dahmen et al., 2001;
Daniels, 1934; Kok et al., 2003; Kotagal et al., 1990; Nishino
et al., 2001; Schuld et al., 2000, 2002). Paradoxically, OX-
deficient humans and mice, develop obesity despite eating
considerably less than their normal counterparts (Fujiki et al.,
2006; Hara et al., 2001; Lammers et al., 1996). Pathogenesis of
obesity in narcolepsy, however, remains unclear. In mouse
models, development of weight gain is partially explained by
diminished energy expenditure as a result of increased sleepi-
ness in these mice (Fujiki et al., 2006; Hara et al., 2001). Total
physical activity is however, not reduced in human narcoleptic
subjects (Middelkoop et al., 1995), suggesting that excessive
daytime sleepiness cannot account for increased body weight
in humans. The fact that narcoleptic patients are more obese
than equally active subjects suffering from idiopathic hypersom-
nia (Kok et al., 2003), suggest that orexin deficiency must
induce basic pathologic alterations that underlie the observedc.
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is associated with impaired BAT thermogenesis that emanates
from the inability of brown preadipocytes to accumulate triglyc-
erides. These findings suggest that energy expenditure derange-
ments, due to BAT hypoactivity, underlie the pathogenesis of
weight gain in narcolepsy.
RESULTS
Orexin Is Required for Thermogenesis and BAT
Triglyceride Storage
We observed that OX-null mice rapidly gained weight on high-fat
diet (HFD) but had little effect when fed a chow diet (Figure 1A),
indicating that lack of OX is more obesogenic in conditions of
calorific excess. At the end of the 6 week HFD regimen, OX-
null mice had increased their body weight by 45%, compared
to the 15% increase in the control mice (Figure 1A). On either
diet, food intake was significantly reduced in OX-null animals
compared to the wild-type mice (Figure 1B), demonstrating
that overconsumption is not the underlying mechanism for
obesity in these animals and is consistent with the earlier report
(Tsuneki et al., 2008). However, OX-null mice gained more
weight per gram of food consumed (Figure S1A available online),
reflecting the enhanced metabolic efficiency of OX-null mice
compared to the wild-type group on HFD (Figure S1A). The
increase in metabolic efficiency despite the reduced food intake
suggested that physiological mechanisms relevant to energy
expenditure might play a role in the pathogenesis of weight
gain. To address this, we performed calorimetric measurements
of physical activity and energy expenditure. Physical activity of
OX-null mice was significantly reduced compared to the wild-
type control and has been reported before (Chemelli et al.,
1999). Interestingly, we noted that diet had no apparent effect
on physical activity, in either genotypic group (Figure 1C). OX-
deficient animals weren’t any less physically active on HFD
than on chow (Figure 1C), and yet they gained weight rapidly
(Figure 1A). This suggested that deficiencies in other compo-
nents of energy expenditure might contribute to the high rate
of weight gain. Investigation of O2 consumption after 6 weeks
of HFD feeding regimen revealed that wild-type mice increased
their metabolic rate by 13% (Figure S1B). This diet-dependent
increase in O2 consumption was completely absent in OX-null
mice (Figure S1C). It is important to note that both the groups
of mice consumed significantly more calories on HFD than
they did on chow (Figure 1B). Wild-type mice on HFD displayed
a 13.5% increase in 24 hr energy expenditure (Figure 1D and Fig-
ure S1C). In contrast, OX-null mice failed to elevate their energy
expenditure in response to HFD (Figure 1D and Figure S1B),
a phenomenon termed as ‘‘diet-induced thermogenesis’’ (DIT).
DIT has been interpreted as a form of defense mechanism
against calorific load in a positive energy balance state (Bach-
man et al., 2002; Kozak, 2010; Rothwell and Stock, 1979). The
main effector of this response is the sympathetic nervous
system, which heavily innervates brown adipose tissue (Bach-
man et al., 2002; Lowell et al., 1993; Lowell and Spiegelman,
2000). It is, however, noteworthy that the significance of BAT in
diet induced thermogenesis, and its role in obesity resistance
has been the focus of much debate (Bachman et al., 2002;
Kozak, 2010; Lowell et al., 1993; Rothwell and Stock, 1979).CellNevertheless, the absence of diet-induced energy expenditure
and O2 consumption in OX knockout (KO) mice prompted us to
investigate their BAT function. Intrascapular BAT (iBAT) was
collected from chow and HFD-fed animals (6 week regimen
described above), and mRNA expression of BAT related genes
known to be induced by HFD was assessed. Failure to increase
the metabolic rate in response to diet was accompanied by
attenuated induction of iBAT thermogenic genes. For example,
Pgc-1a, Tfam, and Ucp1 induction was reduced by an order of
magnitude in OX-null mice compared to the wild-type control
(Figure S1D). This attenuated transcriptional response sug-
gested that there might be an underlying defect in brown-fat
activity forcing metabolic adjustments relevant to obesity in
OX-null mice.
To directly address whether the obesity of OX-null mice was
due to impaired DIT, we monitored metabolic rate of mice
7 days after transition to a HFD. As observed in our previous
set of animals, both the groups significantly increased consump-
tion on HFD (Figure S1F). Body weight and composition were
unaffected by genotype (Figure S1G). Metabolic rate, as indi-
cated by O2 consumption, was significantly lower in OX-null
mice compared to wild-type mice after 5 days of HFD feeding
(Figure 1E). These data indicate that OX-null mice have a failure
of DIT and this may be an important determinant of obesity in OX
deficiency.
To understand why the basic physiological BAT functions
failed in OX-null mice, we compared the iBATs of wild-type
and OX-null chow-fed mice housed at 22C–24C. iBAT from
OX-null micewas normal in size andweight but appeared slightly
pale. Morphological examination after H&E staining revealed
dense clusters of lipid droplets in wild-type iBAT. In contrast,
iBAT intracellular lipids were scarce in OX-null mice (Figure 1F).
A pronounced increase in eosinophilic property imparted a
distinctive ruddy tint to the tissue from orexin-null mice, which
reflected a relative increase in the cytoplasm (Figure 1F). Total
intracellular triglyceride, as measured by glycerol released,
was severely reduced (88% reduction, Figure 1G). This pheno-
type was noted in 100% of OX-null mice regardless of gender.
We also observed that expression of key factors determining
brown-fat differentiation and function was reduced. For ex-
ample, Ppar-g1 mRNA, considered necessary for adipogenesis
(Barak et al., 1999; Rosen et al., 2000), was reduced by an order
of magnitude in iBATs of OX-null mice (Figure S1E). These ob-
servations suggest that OX regulates lipid accumulation in
BAT. Pronounced reduction in iBAT lipid stores in the face of
impaired Ppar-g1, Ppar-g2, Pgc-1a, Pgc-1b, and Ucp-1 mRNA
expression (Figure S1E) suggest that brown adipocytes are
incapable of efficiently synthesizing triglycerides. We speculate
that this may be due to the failure of brown preadipocytes to
differentiate in the absence of OX.
Orexin Is Indispensable for BAT Development
As discussed above, OX deficiency reduced lipid content in BAT.
However, white adipose tissue (WAT) morphology and lipid
content appeared normal (Figure S2A). A brown fat-specific
defect could be either due to the distinct developmental origins
of the two fats (Seale et al., 2008) or the temporal developmental
differences; in rodents, BAT develops during fetal life and con-
tinues until 3–5 days after birth and is most concentrated in theMetabolism 14, 478–490, October 5, 2011 ª2011 Elsevier Inc. 479
Figure 1. Orexin Controls BAT Thermogenesis and Lipid Content
(A) OX KO and C57BL6 wild-type male mice were weaned at 3 weeks of age and fed either a high-fat diet (HFD) or regular chow diet (chow) for 6 weeks. Growth
curves show that OX KO mice are susceptible to diet-induced obesity (p < 0.05; n = 6).
(B) Food intake, expressed as per-mouse basis, of OX KO and C57BL6 control mice on chow and HFD is shown. Both the groups of mice increased their caloric
intake when on HFD.
(C) Physical activity measurements by indirect calorimetry show that physical activity is significantly reduced in OX KO mice regardless of diet. However, HFD
does not further decrease physical activity of OX-null mice (n = 6).
(D) Twenty-four hour energy expenditure is reduced in OX KO mice. Energy expenditure of wild-type and OX KO mice fed either a HFD or chow diet for 6 weeks
after weaning was measured by indirect calorimetry. The data are normalized to lean mass. Unlike wild-type C57BL6 mice, OX KO animals fail to elevate energy
expenditure in response to diet (n = 6).
(E) O2 consumption was significantly lower in OX-null mice compared to wild-type mice 7 days after transition to a HFD (n = 6).
(F) Morphological analysis of BAT from 6- to 8-week-old wild-type and OX KO mice fed on regular chow diet. BAT was dissected from the interscapulary region
and separated from the white adipose element of the tissue. Tissue stained with H&E depicts the lack of lipids with concurrent elevation in eosinophilic (red)
staining in OX KO BAT. Lipids appear as optically blank spheres (representative data from six animals).
(G) OX deficiency severely reduces the triglyceride stores as assessed by iBAT glycerol release. Quantitative measurement of triglycerides in wild-type and OX
KO iBAT sections (n = 6).
Error bars in figures (A)–(E) and (G) represent the standard error of the mean. See also Figure S1.
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Orexin Regulates Brown-Fat Differentiationinterscapular region; white fat develops after birth. To evaluate
the potential role of OX in BAT development, we compared
the iBATs from wild-type and OX-null neonates. No significant
differences were grossly observed between the tissues from
OX-null mice and controls. In neonates, BAT comprises of cells480 Cell Metabolism 14, 478–490, October 5, 2011 ª2011 Elsevier Inat distinct stages of differentiation. Preadipocytes are cells
with no cytoplasmic lipid accumulation. These cells differentiate
into immature adipocytes that contain small cytoplasmic drop-
lets, which then further differentiate into mature adipocytes
containing well-developed lipid droplets. During this perinatalc.
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Figure 2. Ablation of OX Signaling Reduces Lipid and Mitochondrial
Content of Brown Adipocytes
(A) iBAT from wild-type and OX KO newborn pups were sectioned and stained
either with H&E (left) for visualization of general morphology or with Mito-
Tracker Red FM for visualization of mitochondria (right). Note the severe
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CellBAT development stage, fat droplet distribution is typically
dispersed as exhibited by histological examination of wild-type
BAT sections (Tanaka et al., 1997) (Figure 2A). Most brown
adipocytes are also loadedwithmitochondria as seen in Figure 2.
In contrast, fat droplet abundance and size were drastically
reduced in OX-null newborn iBATs. These data are fully consis-
tent with marked iBAT lipoatrophy observed in adult OX-null
animals. Mitochondrial content in iBAT from OX-null mice was
severely reduced (Figure 2B). A survey of transcriptional regula-
tors revealed that Ppar-g1, Pgc-1a, and Pgc-1b mRNA expres-
sion was markedly reduced, suggesting that differentiation in
majority of iBAT cells in OX-null mice may be arrested in the
preadipocyte stage (Figure S2B). It is noteworthy that other
organs, such as heart, skeletal muscles, adrenal medulla, and
thyroid glands, appeared normal upon morphological investiga-
tions (Figure S2C). Together, these observations indicate that
OX is required for proper BAT development.
We considered the possibility that circulating OX might drive
BAT development via direct interaction with its receptor. Evalu-
ation of neonatal or adult BAT mRNA failed to detect Ox ex-
pression (data not shown). Circulating plasma concentrations
of orexin are considered low (30–40 pg/ml) (Adam et al., 2002),
and therefore it may not be able to induce differentiation by direct
receptor-ligand interaction unless produced locally. Indeed, we
noted that placenta producedOxmRNA at moderate levels (Fig-
ure S2D). This is consistent with the observationsmade byNaka-
bayashi et al. (2003), who had previously detected OX-mRNA
expression and OX-A immunoreactivity in the syncytiotropho-
blasts and decidual cells of the placenta (Nakabayashi et al.,
2003). We reasoned that if OX is physiologically required for
BAT development, OX therapy during prenatal growth might
rescue the BAT defect in OX-null pups. To test this hypothesis,
we injected OX in pregnant OX-null mice (three intraperitoneal
injections, 36 hr apart, starting day 14 postcoitum) and analyzed
the BAT from OX-null newborns. The therapeutic regimen had
no noticeable untoward effect on either dams or the neonates
as they were grossly indistinguishable from vehicle injected
OX-null and wild-type C57BL/6 mice. Histological H&E staining
of iBAT revealed a marked improvement in morphology of OX-
null BAT. After OX therapy, most of the adipocytes housed lipids,
indicating that OX was able to support BAT differentiation in
OX-null pups. OX therapy during fetal development also
increased BAT mitochondrial content (Figure 2B, bottom). In
contrast, majority of brown adipocytes from OX-null neonates,
born from vehicle-treated mothers, maintained a morphology
that is consistent with undifferentiated preadipocytes, i.e., lack
of lipid accumulation and reduction in mitochondrial content
(Figure 2B, middle). The rescue of differentiation defect by
OX therapy coincided with near normal mRNA expression ofreduction in intracellular lipids and mitochondria in OX KO iBAT. Represen-
tative images are shown (n = 6).
(B) The defect in BAT development is evident at the time of birth in pups and
can be rescued by maternal OX injections during pregnancy, as assessed by
H&E staining and MitoTracker. Pups from OX KO mice receiving three intra-
peritoneal injections (starting day 13th postcoitum) of 30 mg/kg Orexin A (OX
KO+ OX) or vehicle (OX KO+ Vehicle) were sacrificed and iBAT collected and
stained with H&E or MitoTracker for basic morphological analysis and pres-
ence of mitochondria respectively. Representative images are shown (n = 6).
See also Figure S2.
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Figure 3. Orexin Induces Brown-Fat Programming
(A) Experimental strategy employed to test OX’s effect on adipogenesis. Cells were grown to 70% confluence in high glucose DMEM supplemented with 10%
FBS and treated with vehicle or OX A (100 ng) or BMP-7 (100 ng/28 nM) for 3 days, at which time cells reached 100% confluence. Cells were then incubated in
adipogenic media for 7 days in the absence of OX and BMP-7.
(B) Oil red O staining after treatment with vehicle, OX, or BMP-7. Data are representative of six replicates.
(C) OX-induced differentiation of C3H10T1/2 cells is illustrated by changes in cell morphology, lipogenesis (oil red O stain) and mitochondrial biogenesis
(MitoTracker stain for mitochondria). Images are representative of six replicates.
(D) Cells were pretreated withOXA (100 ng) or BMP-7 (100 ng/ml) or vehicle for 3 days, followed by adipogenic induction for 7 days. RNAwas isolated andmRNAs
relevant to adipogenesis and brown-fat differentiation were quantified with qRT-PCR. Data are expressed as fold values after normalization to 18S RNA
expression (RQ, relative quotient). Data represent at least three independent experiments.
(E) Immunoblotting of proteins functioning in adipogenesis with antibodies against C/EBP1-a, PPAR-gl, PRDM16, PGC1-a, and UCPl after differentiation of
mesenchymal stem cells. Data represent at least three independent experiments.
(F) Equal number of C3H10T1/2 cells were plated and differentiated in 96-well format. Oxygen consumption rates of cells in the absence (basal) and presence of
oligomycin or FCCP are shown. These cells underwent differentiation with either vehicle, BMP7 (100 ng/ml) or Orexin A (100 ng/28 nM). Data represent at least
three independent experiments.
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Orexin Regulates Brown-Fat DifferentiationPPpar-g1, Pgc-1a, and Pgc-1b (Figure S2E), suggesting that
OX relays BAT adipogenic signals via these regulators. These
observations unravel a previously unrecognized role of OX in
embryonic development of BAT.
Orexin-A Induces Brown-Fat Differentiation
Undifferentiated BAT morphology in OX-null pups and its rescue
in pups during fetal growth indicated that OX is required for
BAT development. We postulated that OX might directly bind
to OX receptors on mesenchymal stem cells (MSCs) to induce
brown adipocyte lineage commitment during fetal development.
We tested this hypothesis in cultured C3H10T1/2 MSCs, which
are capable of differentiating into fibroblastic, myogenic, adipo-
genic, osteogenic, and chondrogenic lineages. We first con-
firmed OXR1 mRNA expression in undifferentiated MSCs (Fig-
ure S3A). However OX expression was not detectable in
C3H10T1/2mesenchymal stem cells (Figure S3B). To investigate
whether OX induced differentiation in MSCs, we cultured to
confluence either in solvent or OX for 3 days prior to culturing
them in standard induction medium, as shown in Figure 3A. As
reference, we treated MSCs with a known inducer of BAT differ-
entiation, BMP-7 (Tseng et al., 2008). The rate and extent of
cytoplasmic triglyceride accumulation as measured by oil red
O were comparable to that seen after treatment with BMP-7
(Figure 3B). Differentiation medium alone did not induce signifi-
cant adipogenesis (Figure 3B). Thus, OX induces adipogenesis
in a cell-autonomous fashion.
To investigate whether OX-treated cells differentiated into
brown fat, we assessed the four features associated with BAT
differentiation: the appearance of lipid inclusions, mitochondrial
enrichment, Ucp-1 expression, and uncoupled respiration. To
investigate whether OX induces a brown-fat program, MSCs
were treated (as shown in Figure 3A) with either vehicle or OX
and stained with oil red O on the final day of differentiation. After
OX treatment, more than 90% of the cells assumed the spherical
morphology typical of differentiated fat cells (Figure 3C, ‘‘Bright-
field’’). OX treatment loaded adipocytes with cytoplasmic oil
droplets (Figure 3C, ‘‘Oil Red O’’), and induced extensive mito-
chondrial biogenesis (Figure 3C, ‘‘Mitotracker’’). Early transcrip-
tional regulators of adipogenesis, namely, PRDM16 (Seale et al.,
2008), PGC-1g (Puigserver et al., 1998), PPAR-g1, and C/EBP-a
were elevated both at the mRNA and protein levels (Figures 3D
and 3E and Figure S5). mRNA and protein expression of the
terminal BAT marker, UCP-1, was also induced by OX (Fig-
ures 3D and 3E), suggesting that the differentiated cells had(G) Experimental strategy used to assess differentiation in the HIB1B preadipoc
absence of adipogenic cocktail.
(H) OX-induced differentiation of HIB1B cells as assessed by oil red O staini
experiments.
(I) Experimental strategy used to assess differentiation of primary preadipocytes a
of adipogenesis induction cocktail.
(J) OX-induced differentiation of primary preadipocytes cultured in the absence of
at least six independent experiments.
(K) OX elevates lipogenesis in mouse embryonic fibroblasts. Cells were cultured in
and visualized with oil red O. Images represent at least six independent experim
(L) Differentiation ofmesenchymal stem cells via lentivirus stably expressing orexin
OX A (100 ng). Cells were cultured for 7 days in the absence of differentiation me
experiments.
Error bars in (D) and (F) represent the standard error of the mean. See also Figur
Cellassumed mature brown fat-like characteristics. OXR1 expres-
sion in MSCs remained unchanged during the entire course of
differentiation (Figure S3B).
Undifferentiated C3H10T1/2 cells abundantly expressed
Necdin, preadipocyte factor-1 (Pref-1), andWnt10a, all of which
inhibit early adipogenic events (Kang et al., 2005; Kim et al.,
2007; Smas et al., 1999; Smas and Sul, 1993; Tseng et al.,
2005). Preadipocytes must counter the adipogenic block
imposed by these factors in order to differentiate (Rosen and
MacDougald, 2006). OX treatment of MSCs suppressed mRNA
expression of all three inhibitory factors (Figure S3C). Thus, for
example, Pref-1 expression decreased two orders of magnitude
(Figure S3C). Expression of genes involved in mitochondrial
biogenesis and function, were markedly elevated (Figure 3D
and Figure S3D). This was accompanied by increasedmitochon-
drial abundance in OX-treated cells (Figure 3C). To evaluate
whether this increase in mitochondrial load elevated cellular
respiration, we measured oxygen consumption rates of OX-
differentiated C3H10T1/2 cells and compared to that of control
cells (vehicle treated). An equal number of cells was plated in
96-well format, differentiated as indicated (Figure 1A). Oxygen
consumption rates were measured on day 10 with an extracel-
lular flux analyzer (XF-96, Seahorse Bioscience). OX-treated
cells displayed higher respiration compared to vehicle-treated
cells (Figure 3F, bars 1 and 2), which in all likelihood originates
from mitochondrial enrichment due to efficient differentiation.
In mitochondria of cells other than brown adipocytes, cellular
respiration is tightly coupled to ATP synthesis. UCP1 in mito-
chondria of brown adipocytes however allows uncoupling of
fuel oxidation from ATP production. To investigate whether
OX-differentiated cells displayed uncoupled respiration, we as-
sessed oligomycin-insensitive oxygen consumption. Oligomycin
inhibits ATP synthetase to suppress only oxidative phosphoryla-
tion-associated respiration. As a result, all residual respiration is
due to uncoupling. In OX-treated cells, 50% of respiration was
uncoupled from ATP synthesis, as judged by oligomycin-insen-
sitive oxygen consumption (Figure 3F, bars 2 and 5), which is
an attribute of brown fat (Prusiner et al., 1968). In contrast,
oligomycin completely suppressed respiration in unstimulated
differentiated cells (Figure 3F, bars 1 and 4), indicating that in
the absence of OX, nearly all cellular respiration is coupled to
ATP synthesis. This is consistent with poor basal brown-fat
differentiation of C3H10T1/2 cells in the vehicle-treated cells
(Figures 3C and 3E). In the presence of FCCP, an uncoupler
used to maximize respiratory activity, oxygen consumption ofyte cell line, (d, day). Note that the differentiation assay was performed in the
ng depicting lipid accumulation. Images represent at least six independent
nd mouse embryonic fibroblasts. Differentiation was assessed in the absence
normally required inducing agents and assessed by oil red O. Images represent
the absence of adipogenic media but in the presence of vehicle, OX, or BMP-7
ents.
(Len-OX) compared to vector control in the absence or presence of exogenous
dium and stained with oil red O. Images represent at least three independent
e S3.
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Orexin Regulates Brown-Fat Differentiationunstimulated differentiated cells increased 5-fold (Figure 3F,
bars 1 and 7). Absolute oxygen consumption rate in BMP-7-
and OX-treated cells also increased, though the relative stimula-
tion over the basal rate was less than 2-fold (Figure 3F, compare
bars 2 and 8 and bars 3 and 9). The observation that FCCP had
a moderate effect in OX- or BMP-7-treated cells implies that
basal electron transport activity of these cells is near maximal.
To test the thermogenic potential of OX-differentiated
C3H10T1/2 cells, we measured respiration in the presence of
isoproterenol, a b-adrenergic agonist. Isoproterenol evoked a
four-fold increase in oxygen consumption rate in OX-differenti-
ated cells (Figure S3E). This suggests that differentiated
C3H10T1/2 cells resemble brown adipocytes and can execute
a thermogenic program (Figure 3F). Together, these data indicate
that OX is a potent regulator of brown-fat adipogenesis in MSCs.
Next, we evaluated the role of OX in differentiation of a well-
established model cell line, HIB1B, for brown preadipocytes
(Ross et al., 1992). These cells express moderate levels of
OXR1 (Figure S4A) and OX expression is not detectable (data
not shown). Remarkably, OX treatment of HIB1B cells for just
24 hr induced extensive lipid accumulation in the absence of
the adipogenic cocktail (Figures 3G and 3H). Expression of
genes functioning in lipid metabolism and mitochondrial biogen-
esis and uncoupled respiration was elevated (Figure S4B). OX
also induced differentiation of primary brown adipocytes, iso-
lated from 1-day-old wild-type C57BL6 mice. OX-treated cells
displayed robust adipogenesis within 7 days (Figure 3J) in the
absence of adipogenic cocktail. Mouse embryonic fibroblasts
(MEFs) resemble mesenchymal cells in their ability to differen-
tiate into various mesenchymal lineages (Ntambi and Young-
Cheul, 2000). To determine whether OX triggers commitment
of embryonic fibroblasts to a BAT lineage, we exposed MEFs
isolated at P13.5 to a differentiation protocol usingmedia lacking
the induction cocktail (as described in Figure 3I). As can be seen
in Figure 3K, OX induced robust differentiation in embryonic
fibroblasts. Increase in differentiation coincided with elevated
mRNA expression of Prdml6, Ppar-g1, Ppar-g2, and Sirt3
mRNAs, Tfam, Cox7a1, and Ucp1 (Figure S4C).
To investigate whether endogenous OX drives BAT differenti-
ation, we stably transfected C3H10T1/2 cells with lentivirus
overexpressing orexin. By day 6 of adipogenic differentiation,
OX-expressing cells had undergone normal BAT differentiation,
as scored by lipid accumulation. The extent of lipid accumulation
in orexin-expressing cells was comparable to that seen in cells
treated with exogenous OX (Figure 3L). Taken together, these
data show that OX activates a full program of brown-fat adipo-
genesis in vitro, by suppressing adipogenic inhibitors, inducing
BAT fate regulators, elevating mitochondrial biogenesis and
oxygen consumption, and inducing uncoupled respiration. Im-
portantly, OX can drive brown-fat differentiation in the absence
of adipogenic cocktail.
OXR1 Relays OX’s Function in BAT Differentiation
OX triggered brown-fat differentiation in C3H10T1/2 cells, which
expressed only Oxr1, suggesting that OX couples to OXR1 to
induce differentiation. To examine the cellular and molecular
consequences of OXR1 depletion, we used lentiviral vector to
express a short hairpin RNA (shRNA) targeting OXR1 (shOXR1)
or a scrambled shRNA control in HIB1b cells. Oxr1 mRNA was484 Cell Metabolism 14, 478–490, October 5, 2011 ª2011 Elsevier Invirtually undetectable in cultures expressing the shOXR1 con-
struct (Figure S4D). In the absence of OX, brown preadipocytes
expressing scrambled shRNA did not differentiate efficiently
(Figure 4A). By day 6 of differentiation, OX-treated cultures
expressing the scrambled shRNA had undergone robust
brown-fat differentiation as scored by oil red O staining (Fig-
ure 4B). By contrast, OX failed to drive differentiation in OXR1-
knocked down cells (Figure 4C). OXR1 depletion blunted both
OX-dependent lipidogenesis and mitochondrial biogenesis
(Figure 4C). Treatment of HIB1b cells with OXR1 selective antag-
onist (SB408124) also blunted OX-induced lipid accumulation
and mitochondrial biogenesis (Figure 4D). These results strongly
suggest that OX couples to OXR1 to elicit BAT differentiation.
To investigate whether OXR1 signaling pathway was required
for hormonal cocktail-assisted differentiation we cultured wild-
type and OXR1-depleated HIB1b cells in the presence of stan-
dard adipogenic cocktail. OXR1-depleated HIB1b cells did not
display any detectable differentiation defect in the presence of
hormonal cocktail (data not shown). These data indicate that
adipogenic cocktail is able to bypass the need for OXR1 signal
activation in inducing brown-fat differentiation. We conclude
that OXR1 pathway is not required for the standard hormone-
mediated differentiation of HIB1b preadipocytes.
To demonstrate that OXR1 is critical for brown-fat differentia-
tion, we compared the differentiation capacity of primary brown
preadipocytes isolated from wild-type C57BL6 and OXR1 KO
mice, in the absence of exogenous adipogenic factors. Primary
preadipocytes from wild-type C57BL/6 mice express Oxr1 but
not Ox (data not shown). As shown in Figure 4E, primary adipo-
cytes from wild-type mice differentiated into adipocytes and
accumulated lipid droplets. OX treatment of the wild-type
primary brown adipocytes increased the basal adipogenesis
(Figure 4F). In striking contrast, differentiation of brown preadi-
pocytes from OXR1-null mice was significantly reduced, even
when treated with orexin (Figure 4G). This suggests OXR1 is
required for basal BAT differentiation. mRNA expression of the
adipocyte marker, Ppar-g2, and the terminal marker Ucp-1
increased in wild-type brown adipocytes during differentiation.
In contrast, the expression of preadipocyte marker, Pref-1, de-
clined. Preadipocytes from OXR1-null mice, on the other hand,
continued to express Pref1. In addition Ppar-g and C/ebp
expression is reduced in OXR1-null preadipocytes, suggesting
that OXR1 executes brown-fat differentiation function of OX.
However, when cultured in the presence of standard adipogenic
cocktail, OXR1-null preadipocytes differentiate as efficiently
as wild-type preadipocytes. This suggests that OXR1 signal
activation is not required for hormone-assisted brown-fat
differentiation (data not shown). Interestingly, BMP-7 treatment
of OXR1-null brown preadipocytes, the rescued the adipogenic
defect and restored the differentiation capacity to the wild-type
levels (Figure 4H). This suggests that (1) orexin-triggered
brown-fat differentiation, at least in part, may be mediated by
BMP-7 and (2) OXR1-null BAT is fated correctly.
Orexin Triggers Brown Adipocyte Differentiation
via Smad and p38 MAPK Signaling
In inducing brown-fat differentiation, BMPs binds to BMPR1A
and activate a signaling cascade through Smad 1/5, leading to
p38 MAPK activation (Cao et al., 2004; Hata et al., 2003; Tsengc.
Mitotracker
+ DAPI
Vehicle OX
OX+OXR1-AntagonistOX + OXR1 shRNA
Oil Red O
Primary preadipocytes 
E
Oil Red O staining
Oil Red OMitotracker
+ DAPI
HIB1 brown preadipocytes
A B
C D
F
G H
C57BL6+vehicle C57BL6+OX
OXR1KO+OX OXR1KO+BMP-7
Figure 4. OXR1 Is Essential for Brown-Fat Differentiation
(A and B) Oil red O staining for lipid accumulation (left panel) and MitoTracker
staining for mitochondria (right) after 5 days treatment with vehicle (A) or OX A
(B) (100 ng). Nuclei were stained with DAPI.
(C) Differentiation of HIB1B brown preadipocytes after OXR1 knocked down
by infection with lentivirus containing shRNA targeting OXR1 and treated with
OX A (100 ng) for 5 days.
(D) Differentiation of HIB1B brown preadipocytes treated with OX A (100 ng) in
conjunction with the OX R1 selective antagonist SB408124 (1 mM) for 5 days.
OX couples to OXR1 to induce brown-fat adipogenesis.
(E–H) Oil red O staining for lipid accumulation in primary brown preadipocytes
cultured from C57BL/6 wild-type cells and treated with either vehicle (E) or OX
A (100 ng) (F) for 7 consecutive days to induce differentiation, or in primary
brown preadipocytes cultured from OXR1 knockout (OXR1 KO) mice and
treated with either OX A (100 ng) (G) or BMP7 (l00 ng/ml) (H) for 7 consecutive
days to induce differentiation. All treatments were in the absence of any adi-
pogenic components (indomethacin, IBMX, dexamethasone,). All images
represent at least four independent experiments.
See also Figures S4 and S5.
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Orexin Regulates Brown-Fat Differentiationet al., 2008). In MSCs, OX induced mRNA expression of Bmp-7
and its receptor Bmpr1a (Figures 5A and 5B) and also stimulated
Smad 1/5 phosphorylation (Figure 5C). Indeed, orexin treatment
of MSCs faithfully recapitulated the BMP-7-driven differentiationCellprogram, as illustrated by the amplitude and the temporal down-
stream response of key regulators during the entire course of
differentiation (Figures S3D and S5). For example, expression
patterns ofmitochondrial transcription factor (Tfam), cytochrome
oxidase (Cox7A, Cox8B), deiodinase-2, Ucp-1, and transcrip-
tional regulators such C/ebp, Prdm16, and Ppar-g were super-
imposable (Figures S3D and S5). These data demonstrate that
OX induces ‘‘BMP-7-like’’ brown-fat programming.
To address whether OX-induced differentiation was mediated
via canonical BMPR1A dependent mechanism, we used lentivi-
ral vectors to express a shRNA targeting BMPR1A (shBMPR1al)
or a scrambled shRNA control in mesenchymal cells and then
assessed the ability of OX to phosphorylate Smad 1/5 and p38
MAPK. Bmpr1a mRNA expression was reduced by more than
90% (Figure S6). Depletion of the receptor blunted OX-induced
Smad 1/5 phosphorylation (Figure 5D). OX-induced Smad 1/5
phosphorylation was absent in BMPR1A-knocked down cells.
In inducing brown-fat differentiation, p38 MAPK pathway relays
many functions of BMPs and is required for adipogenesis
(Cao et al., 2004; Hata et al., 2003; Tseng et al., 2008). Inter-
estingly, OX increased phosphorylation of p38 MAPK but
did not require the presence of Bmpr1a (Figure 5D). However,
both basal and OX-induced p38 MAPK phosphorylation was
reduced. This supports a model in which OX couples to OXR1
to elicit brown-fat differentiation by concomitantly activating
BMPR1A dependent Smad-and p38 signaling. Consistent
with this, OX robustly activated Smad 1/5 and p38 MAPK in
wild-type primary brown preadipocytes, a response that damp-
ened in primary brown preadipocytes from OXR1-null mice (Fig-
ure 5E). That these two pathways are important for OX-mediated
differentiation is further reinforced by the findings that pharma-
cological inhibition of either BMPR1a (by dorsomorphin [Yu
et al., 2008]) or p38 MAPK blunted OX-induced lipid accumula-
tion (Figure 5F).
OXR1 signaling is known to activate phospholipase C pathway
(PLC) (Ammoun et al., 2006; Johansson et al., 2007) and lies
upstream to p38 MAPK. To determine whether PLC was neces-
sary for OX-induced differentiation, we differentiated C3H10T1/2
cells in the presence or absence of PLC inhibitor (U73122).
OX-induced lipidogenesis was substantially reduced in the
presence of the inhibitor (Figure 5G). This data suggests that
OXR1 couples to phospholipase C (PLC) activation, which then
stimulates p38 MAPK to induce adipogenesis. The second arm
of OX signaling is relayed via Smad 1/5 phosphorylation in a
BMPR1A-dependent manner to recruit cellular components
necessary for brown-fat adipogenesis (Figure 6). Both the
signaling components contribute to OX-dependent differentia-
tion such that inhibition of either pathway impairs the transition
of stem cells to brown adipocytes.
DISCUSSION
The present study shows how OX controls thermogenesis in
adult life and brown-fat differentiation during fetal growth; and
how its lack permanently programs obesity in rodents. The
results and broad conclusions drawn from OX-null narcoleptic
mouse model and in vitro cell culture is relevant to the under-
standing of energy expenditure regulation and in the control of
obesity in general.Metabolism 14, 478–490, October 5, 2011 ª2011 Elsevier Inc. 485
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Figure 5. OX Activates Smad and P38
MAPK Signaling to Induce Adipogenesis
(A and B) mRNA expression levels of Bmpr1A (A)
and Bmp-7 (B) in C3H10T1/2 cells treated with
100 ng OX A or vehicle for 3 days followed by
adipogenic induction with dexamethazone, IBMX,
and indomethacin. RNA was isolated every 24 hr
for the duration of differentiation and target tran-
scripts measured (n = 6 replicates).
(C) Western blot showing an increase in pSmad
1/5 in C3H10T1/2 cells treated with 100 ng OX A or
BMP7.
(D) Western blots for pSmad 1/5, phospho-
p38MAPK, and beta actin in C3H10T1/2 cells in
whichBMPR1awasknockeddownby transfection
with lentiviral shRNA or which were transfected
with lentiviral vector only and treated with 100 ng
OX A for 0, 30, and 60 min. Note the attenuation of
orexin-induced smad 1/5 and p38 MAPK phos-
horylation in BMPR1a-knocked down cells.
(E) Western blots pSmad 1/5, phospho-p38MAPK
and beta actin in primary brown preadipocytes
cultured from wild-type and OXR1 KO mice and
treatedwith 100 ngOXA for 0, 30, and 60min. Note
the reduced levels of orexin-inducedSmad1/5and
p-p38 MAPK phosphorylation in primary brown
preadipocytes lacking OXR1. All immunoblots are
represent four independent experiments.
(F) Oil red O staining showing a reduction in OX
A-induced and BMP7-induced lipid accumulation
byBMPR1a inhibitor Dorsomorphin (5mM)andp38
MAPK inhibitor (10 mM). Cells were treatedwith OX
A, BMP7, vehicle, or OX A and BMP7 in conjunc-
tion with the BMPR1A inhibitor or p38 MAPK
inhibitor for 3 days followed by adipogenic induc-
tion for a further 7 days.
(G) Oil redOstaining showing reducedOXA-induced lipid accumulation byPLC inhibition. C3H10T1/2 cells were treatedwith 100 ngOXAand 10 mMPLC inhibitor
U73122. Images represent four independent experiments.
Error bars in (A) and (B) represent the standard error of the mean. See also Figure S6.
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Orexin Regulates Brown-Fat DifferentiationTypically, obesity is associated with overeating. Orexin is an
appetite-inducing neuropeptide and therefore it is not surprising
that lack of OX reduces energy intake (in OX-null mice). What is
surprising though, is their susceptibility to rapid weight gain. This
study describes the pathogenesis of weight gain in OX-deficient
narcoleptic mice, when fed a high-fat diet. In wild-type rodents,
transition from low to high-fat diet is associated with 13% eleva-
tion in metabolic rate, arguably as defense against weight gain.
OX-deficient animals lack this regulatory mechanism as they
fail to elevate their metabolic rate when challenged with high-
fat diet. These results indicate that OX controls energy expendi-
ture via its effect on BAT adaptive thermogenesis. Lack of OX
inactivates BAT adaptive thermogenesis, a critical energy dissi-
pation mechanism in response to high caloric diet. Failure of this
metabolic adaptation mechanism dampens energy expenditure,
resulting in rapid weight gain in OX-null mice.
Histological analyses revealed severe lack of intracellular
triglycerides in OX-null iBATs. The lack of triglycerides is likely
due to defective maturation of pre-adipocytes, though the lesion
would also be consistent with impaired triglyceride synthesis.
Obesity, in general, is associated with increase in BAT intracel-
lular triglycerides (Bachman et al., 2002; Liu et al., 2003; Seale
et al., 2008; Tateishi et al., 2009). Thus, at first glance, the striking
disappearance of BAT triglyceride stores in OX-null mice486 Cell Metabolism 14, 478–490, October 5, 2011 ª2011 Elsevier Inappears to be at odds with its obese phenotype. In b-less
mice, for example, intracellular lipids accumulate due to lack of
b-adrenergic receptors (Bachman et al., 2002). In contrast,
adipogenesis is drastically reduced in OX-null mice due to differ-
entiation defect. The resultant effect in both the scenarios is,
however, the same—failure of BAT adaptive thermogenesis
and rapid increase in adiposity. It is noteworthy that the defect
in triglyceride accumulation is BAT selective (in OX-null mice).
Adipogenesis in white adipose tissue remains unaffected. Mech-
anisms that confer such selective regulation is of fundamental
interest since it permits selective targeting of BAT adipogenesis
to activate BAT metabolism.
Another surprising observation was the essential role of OX in
the regulation of brown-fat development. Our study reveals that
iBAT differentiation defect originates during fetal growth as OX-
null neonatal and adult BAT display similar pathological lesion.
Mechanism by which OX regulates iBAT developmental differen-
tiation is not clear. Circulating OX levels are not high enough to
directly induce differentiation during development. The observa-
tion that placenta expresses OX raises the possibility that locally
produced neuropeptide may mediate BAT development by
directly binding to the receptor-expressing mesenchymal cells.
Regardless of the mechanism, the finding that OX-replacement
therapy of OX-null dams rescue BAT developmental defect inc.
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Figure 6. Model of OX-Induced Differentiation
Orexin binding to OXR1 induces phospholipase C (PLC) activation, which then
stimulates p38 MAPK to activate brown-fat adipogenesis. The second arm of
OX signaling is relayed via Smad 1/5 phosphorylation in a BMPR1A-depen-
dent manner. Both the signaling arms contribute to OX-dependent differenti-
ation such that inhibition of either pathway impairs brown-fat differentiation.
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Orexin Regulates Brown-Fat DifferentiationOX-null pups strengthens OX’s role in development. These
observations unravel a previously unrecognized role for OX in
embryonic development and prompt several pertinent questions
central to the control of narcolepsy-related obesity: (1) whether
correction of iBAT morphological defect in OX-null pups will
restore thermogenic defect and (2) whether iBAT morphological
and thermogenic defects can be corrected after birth—and, if so,
whether correcting iBAT development before or after birth will
suppress subsequent obesity in adult OX-null narcoleptic mice.
The observation that embryonic loss of OX induces obesity
due to pathophysiogical changes in BAT corroborates the idea
that obesity can have its origin in fetal life (Ravelli et al., 1999;
Ravelli et al., 1976). Prenatal BAT development is an important
area that has seen little progress in recent years, barrier being
the lack of appropriate models. While perinatal BAT growth
and differentiation is controlled by sympathetic nervous activity,
sympathetic innervations do not appear to be required for fetal
BAT development (Symonds et al., 2003). Little information
exists concerning the identity and nature of signals that regulate
BAT development in utero. It is important to understand prenatal
BAT development as obesity in adult life can be influenced by
early events during fetal growth, as illustrated in this study.
When administered in the brain OX elevates sympathetic
activity leading to rise in body temperature, arterial blood
pressure, heart rate, and O2 consumption (Bamshad et al.,
1999; Monda et al., 2004, 2007; Samson et al., 2007; Shirasaka
et al., 2002). Therefore, lack of OX could reduce the general
sympathetic tone and potentially impact BAT development:
a mechanism yet to be described. Existing evidence suggest
that sympathetic activity is not required for fetal BAT develop-
ment (Symonds et al., 2003). Heart, which shares the same
degree of sympathetic innervations as BAT (Barnard et al.,
1980), displayed no noticeable morphological defect in OX-null
mice. Skeletal muscles, adrenal medulla, and thyroid glands,
which receive sympathetic inputs, also appeared normal uponCellmorphological investigations. This suggests that sympathetic
tone is not systemically reduced, at least not to the extent of
asserting a general developmental defect. Furthermore, sympa-
thetic under-activity (if any) is expected to elevate lipid accu-
mulation rather than reducing it (Eikelis and Esler, 2005). Hence,
depletion of BAT intracellular fat droplets in OX-null mice is not
consistent with sympathetic under-activity and indicates
existence of a different mechanism by which OX controls BAT
developmental differentiation. Our results suggest that locally
produced OX can directly bind to the OXR1-expressing mesen-
chymal stem cells and control BAT developmental differentiation
program. Consistent with this hypothesis, OX drives robust
brown-fat differentiation in cultured mesenchymal stem cells,
as indicated by robust adipogenesis, mitochondrial biogenesis,
Ucp-1 expression, and uncoupled respiration. Interference with
OX signaling either by pharmacological (receptor antagonist)
or genetic means (OXR1 knockdown) blunts OX dependent
brown-fat differentiation in cultured cells. In line with this,
OXR1-null primary brown preadipocytes fail to differentiate
efficiently. OXR1-deficient preadipocytes appear to be fated
properly as the differentiation defect is rescued by BMP-7.
This observation also indicates that OX-triggered brown-fat
differentiation program involves BMP signaling pathway. The
finding that OX induces robust smad 1/5 phosphorylation, the
mediator of BMP signaling, further reinforces this hypothesis.
Molecular mechanism of how OX transactivates BMP signaling
is not understood but likely involves BMPs or BMP modulators
as OX fails to induce smad 1/5 phosphorylation and adipogene-
sis in BMPR1A-depleted mesenchymal stem cells.
It is also noteworthy that OX-null mice serves as a unique
mouse model in that a loss of appetite-inducing factor impairs
BAT activity. Feeding and energy expenditure tend to work in
a reciprocal fashion to maintain body weight. Thus, neuropep-
tides that increase feeding when administered into the CNS
tend to decrease energy expenditure. Considerable evidence
suggests that the evolution and purpose of this system is to
conserve energy: that is to, seek food in times of need and store
energy in times of plenty. Hence, this homeostatic system is
biased strongly toward weight gain and fat storage. OX is
uniquely positioned as it induces both feeding and energy
expenditure. However, the mechanism whereby this appetite-
inducing agent drives energy expenditure was unclear. The
findings reported in this study bridges this gap by forging a link
between OX and BAT physiology, which is a key energy expen-
diture pathway in rodents. A major fallout of this finding is in
extending the utility of narcoleptic mouse models beyond the
gamut of narcolepsy. These models (OX null, OXR1 null, OXR2
null) are uniquely poised to help understand the fundamental
interactions among feeding, BAT differentiation, and energy
expenditure pathways in the control of body weight. In addition,
brown preadipocytes from the aforementioned models will be
instrumental in teasing apart the transcriptional and signaling
players in the control of BAT differentiation and adipogenesis.
A plethora of reports show a strong association between low
plasma OX and obesity in humans (Knutson and Van Cauter,
2008; Kok et al., 2003; Smart et al., 2002). Though it’s difficult
to extrapolate animal studies into humans, findings reported
here predict that the sensitivity to obesity in OX deficiency could
be primary to hypoactive BAT, given that total physical activityMetabolism 14, 478–490, October 5, 2011 ª2011 Elsevier Inc. 487
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Orexin Regulates Brown-Fat Differentiationremains unchanged in human narcoleptic subjects (Middelkoop
et al., 1995). Assessing BAT activity in OX-deficient narcoleptic
patients can easily test this postulate. Our findings also highlight
the relevance of functional BAT in the regulation of body weight
homeostasis. Increasing energy expenditure by enhancing BAT
function through differentiation would be a viable approach to
prevent or reduce obesity. This warrants future studies investi-
gating the potential of OX or OXR1 agonists in improving BAT
function and triggering weight loss. One caveat is that OX might
increase arousal, although this is expected only under sleep
deprived conditions (Deadwyler et al., 2007).
EXPERIMENTAL PROCEDURES
Recombinant human BMP7 (catalog number 4579) was purchased from
BioVision, and humanOrexin A was purchased from Anaspec (catalog number
24470). For western blot analysis, antibodies were purchased from Santa Cruz
Biotechnology (CEBPa, catalog number 2843; PPARg, catalog number 2492),
Cell Signaling (Phospho-Smad 1/5/8, catalog number 9516; PGC1, catalog
number 4259), and Abcam (UCP1, catalog number 23841; PRDM16, catalog
number 3789). Transfer membranes were from Invitrogen and electrophoresis
supplies were from Bio-Rad Laboratories. All other chemicals were purchased
from Sigma Chemical Company unless otherwise specified.
Animals
C57BL6 mice were purchased from Jackson Laboratories. Orexin and Orexin
receptor knockout mice were either a gift from Prof Masashi Yanagisawa
(University of Texas Southwestern, Dallas, TX) or purchased from Jackson
Laboratories (B6.129B6.129S6-Hcrttm1Ywa/J).Allmicewerehousedunder stan-
dard vivarium conditions with a 12 hr light-dark cycle unless otherwise stated.
Cell Culture
C3H10T1/2 cells were purchased from American Type Culture Collection.
Generation of wild-type primary brown preadipocyte cell lines derived from
newborn wild-type mice was as described previously (Klein et al., 2002).
MEF isolation was as described previously (Conner, 2001). The HIB1b mouse
brown preadipocyte cell line was a gift from Sheila Collins. All cell lines used in
this study were maintained in Dulbecco’s modified Earle’s medium (DMEM),
(4.5 g/liter glucose, 4 mM glutamine; Hyclone #SH30243.01), supplemented
with 10% fetal bovine serum at 37C in 5%CO2 environment unless otherwise
specified. To induce adipogenesis in C3H10T1/2, cells were treated for 3 days
with either BMP7 (100 ng/ml) or Orexin A (100 ng/28 nM), at which time they
were confluent. Cells were then incubated in adipogenic medium containing
0.125 mM indomethacin, 5 mM dexamethasone, and 0.5 mM 3-isobutyl-1-
methylxanthine (IBMX) supplemented by 20 nM insulin and 1 nM triiodothyro-
nine as described by Tseng et al. (2008). HIB1 cells and primary brown
adipocytes and MEFs were treated for 3 days with Orexin A and BMP7 and
differentiated in the absence of induction medium for a further 7–10 days
unless otherwise stated. To understand the signaling mechanisms involved
in OX induced adipogenesis, we used BMPR1a inhibitor Dorsomorphin
(10 mM) (Tocris Bioscience, 3093), P38 MAPK inhibitor (Santa Cruz,
sc-204157) and phospholipase C (PLC) inhibitor U73122 (Santa Cruz,
sc-3574) during the 3 days treatment of C3H10T1/2 cells with OX A or BMP7.
Lentiviral Constructs
shRNA lentiviral vector targeting mouse BMPR1a, OXR1 and the nontargeting
control vector were purchased from Open Biosystems (Huntsville, AL). All
vector constructs were then transfected into HEK293 cells, respectively.
Supernatants containing viruses were collected 48 hr after transfection
and C3H10T1/2 target cells were transduced with 10 mg/ml polybrene. Stable
infected cell lines with encoded vector were selected by 2 mg/ml puromycin
resistance and used for further studies.
Q-RT-PCR Analysis
Total RNA was isolated with Trizol lysis reagent (QIAGEN) and purified by
RNeasy Mini columns (QIAGEN) according to the manufacturer’s instructions.488 Cell Metabolism 14, 478–490, October 5, 2011 ª2011 Elsevier InComplementary DNA was prepared from 1 mg of RNA with the RT-PCR
kit purchased from Applied Biosystems, according to the manufacturer’s
instructions and diluted to a final volume of 100 ml. One microliter of diluted
complementary DNA was used in a 25 ml PCR reaction with SYBR Green
Master Mix (Applied Biosystems) and primers at a concentration of 250 nM
each. PCR reactions were run in duplicate for each sample and quantified in
the ABI Prism 7000 Sequence Detection System (Applied Biosystems). Data
were expressed as arbitrary units after normalization to levels of expression
of the internal control beta actin or 18s RNA. All primers were synthesized
by Integrated DNA Technologies. A full list of primers and their sequence
appears in Table S1.
Oil Red O Staining
Cells were washed twice with phosphate-buffered saline (PBS) and fixed with
10% buffered formalin for 1 hr at room temperature. Cells were washed twice
in PBS and then stained for 30 min at room temperature with a filtered oil red O
(Sigma) solution (0.5% oil red O in isopropyl alcohol), washed twice with PBS,
and stored in PBS for visualization under the inverted microscope (Olympus).
Western Blot Analysis
Cells were collected in lysis buffer (50mMHEPES, 137mMNaCl, 1mMMgCl2,
1 mM CaCl2, 10 mM Na2P2O7, 10 mM NaF, 2 mM EDTA, 10% glycerol, 1%
Igepal CA-630, 2 mM vanadate, 10 mg ml1 leupeptin, 10 mg ml1 aprotinin,
and 2 mM phenylmethylsulfonyl fluoride [pH 7.4]). After lysis, lysates were
clarified by centrifugation at 12,000 g for 20 min at 4C; the protein amount
in the supernatants was determined by the Bradford Protein Assay (Bio-Rad
Laboratories). Proteins were directly solubilized in Laemmli sample buffer.
Equal amounts of proteins were separated by SDS-polyacrylamide gel
electrophoresis and transferred to Immobolin-P membranes. Membranes
were blocked overnight at 4C and incubated with the indicated antibody
for 2 hr at room temperature. Specifically bound primary antibodies were
detected with peroxidase-coupled secondary antibody and enhanced chem-
iluminescence (Amersham Biosciences).
Histology and Immunofluorescence
Tissues were fixed in 10% formalin and were paraffin-embedded. Multiple
sections (5 mm) were prepared and stained with hematoxylin and eosin
for general morphological observation. For mitochondrial staining with Mito-
Tracker Red FM, cells were incubated with prewarmed medium containing
the MitoTracker probe at a working concentration of 250 nM. Cells were
then fixed in 4% formaldehyde and observed with a fluorescence microscope.
iBAT Rescue in OX KO Pups
Pregnant OX KO mice were injected intraperitoneally with 30 mg/kg Orexin A
or vehicle (three intraperitoneal injections, 36 hr apart, starting day 13 postcoi-
tum). At birth, pups were sacrificed, and iBAT was harvested and processed
for H&E and mitochondrial staining with MitoTracker Red FM.
Image Analysis
Image analysis was conducted with the software Nikon Elements. The analysis
measured the percent fluorescence based on pixilation in various fields and
calculated mean fluorescence.
In Vitro Oxygen Consumption
The oxygen consumption rate (OCR) of cells in culture was derived with the
Extra-Celllular Flux Instrument (XF-96), which was purchased from Seahorse
Bioscience. This instrument is capable of measuring accurately the mitochon-
drial oxidation and glycolysis in a microplate format. Cells were differentiated
in XF-96 cell culture plates provided by Seahorse and following complete
differentiation (after 10 days) the basal OCR was measured for 30 min, after
which cells were treated with 200 mM 8-CPT-cAMP (a cell-permeable form
of cAMP, Santacruz #sc-201569), 8 mM carbonyl cyanide p-(trifluorome-
thoxy)phenylhydrazone (FCCP), or 3 mM oligomycin.
BAT Triglyceride Content
Brown adipose tissue was homogenized in 1 ml saline solution, and Triglycer-
ides (GPO) Reagent Kit (Pointe Scientific) was used to determine triglyceride
concentration in the tissue.c.
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Data analysis was performed with SPSS (statistical product and service
solution software, IBM) software. Comparisons were tested with paired and
unpaired t tests. Linear regression analyses were conducted to identify
correlations between variables. p values less than 0.05 were marked by
asterisk and considered statistically significant. Error bars represent standard
error of the mean.
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